In March 2025, the company announced new plans for any immediate-to-buyer offering of its Wegovy weight loss drug. The company established a new pharmacy, known as NovoCare, which would cost clients $499 each month for use of the drug, fewer than half the price of the drug by other pharmaceutical distribution networks.[fifty three]inflammation with